PRELIMINARY STUDIES ON RED BELLY TILAPIA COPTODON ZILLII CAUGHT FROM OYAN DAM, OGUN STATE, NIGERIA

The study was carried out on the biological aspect of Redbelly Tilapia, Coptodon zillii collected from Oyan Lake, Abeokuta North Local Government Area, Ogun State, Nigeria, with the aim of contributing to the baseline data for carrying out further studies on its ecology, conservation and development. A total of two hundred and fifty four fish (254) specimens were caught from the Ibaro landing site of the Lake between March and July, 2015. The total length (cm), standard length (cm), head length (cm), body width (cm), body depth (cm), snout length (cm), eye diameter (cm) and body weight (g) were measured. The stomach content was also assessed in order to determine its food and feeding habit. The mean total-length, standard-length, head-length, eye-diameter, snout-length, body-depth, body-width and body-weight during the study were 10.98±0.61cm, 8.56±0.14cm, 2.5±0.08cm, 3.67±0.15cm, 1.52±0.11cm,1.37±0.17cm, 4.05±0.07cm, 34.25±3.02g respectively and their ranges were (4.5-18.7cm), (3.2-15.2cm), (1.1-5.8cm), (2.0-6.8cm), (0.8-3.0cm), (1.1-4.8cm), (1.4-7.3cm) and (6.0-132.0g). A negative allometric (b<3) growth pattern was observed for the stock. The meristic characteristics of C. zillii were (DFR) XIV 10 – XVI 14; PVR, AFR III 8 –III 9; PFR 10 – 13 respectively. Stomach analysis showed that diatoms were the most abundant food items in the diet of C. zillii numerically, 29.98%, while desmids were the most abundant food items in terms of frequency occurrence, 27.82%. This study concluded that C. zillii is not morphometrically and meristically different from the already classified from previous studies. Also, C. zillii thrives well on available plants and detritus.   &nbsp

Morpho-chemical divergence and fatty acid profile of shea tree seeds (Vitellaria paradoxa) collected from different locations in Kwara State, Nigeria

The present study characterizes seed-related traits, phytochemical, physiochemical parameters and fatty acid profile of shea (Vitellaria paradoxa) seeds collected from the Kosubosu, Fufu and Sare areas of Kwara State, Nigeria to determine the effects of microclimate on seed morphology, biochemical and oil constituents. Seed morphological data were analyzed for variability. Seed oil was extracted for phytochemical constituents, physicochemical properties, and fatty acid profiling by gas chromatography equipped with mass spectrometry (GC/MS). Results showed intra and inter-locational variations in seed characters. Most fruits had 1–2 seeds. Seeds were predominantly brown and very few were dark brown. Phytochemicals and physicochemical parameters of the seed oil varied with place of collection. Alkaloid, saponin, tannin and phytate contents ranged between 0.79–0.84, 1.20–1.26, 1.48–1.56 and 0.15–0.18 mg g–1 respectively. The density of the oil was less than that of water, acid value ranged from 10.58–13.56 mg KOH g–1 and iodine values were between 36.63 to 40.32 g I2 (100 g)–1. Saponification values lie between 160.39 and 184.14 mg KOH g–1; and free fatty acid was within 5.32–6.81 %. Peroxide, ɑ-tocopherol, total phenol and oxalate values as well as viscosity of the oil also varied; however, refractive index was similar. Ethyl oleate and octadecanoic acids were present and most abundance in all the locations, while glycidol stearate was only found in Fufu samples with three other fatty acids. Five fatty acids were present in Kosubosu, while Sare had only two. The results obtained in the present study indicate that shea oil could be used for medicinal, nutritional and industrial purposes. Since seed characters, phytochemical, physicochemical and fatty acid compositions varied with the microclimate, environmental and micro-ecological conditions should be considered when collecting seeds for oil utilization

Heterogeneous catalytic conversion of 4-chlorophenol via atomic hydrogen substitution induced by size-controlled polydisperse nanocobal

Hyroconversion of 4-Chlorophenol (4-CP) was induced via atomic hydrogen substitution and 0.5–2 M polydisperse cobalt nanoparticles (40–500 d.nm) which were synthesized via a modified-polyol route. The cobalt nanoparticles and hydrogen incursion in the 4-CP helped to enforce the hydroconversion (HDC) reaction of 4-CP. The reaction runs were conducted based on an initial 4-CP wastewater effluent concentration discharged from a pesticide company, different particle sizes, and reaction time. Also, NaOH was added as a proton scavenger to the reaction mixture in order to avoid catalyst-deactivation. Samples from the reactor were collected at different times in order to monitor the hydroconversion process. The Co-catalyst reduced the activation energy of the reaction, initiated the hydro-substitution reaction at an earlier time, as well as enhanced 4-CP hydroconversion. Of all the catalysts, the 2 M polydisperse-cobalt nanoparticles (PD-CoNPs) gave the best performance with a description that fits the desorption mechanism whose keqd value = 0.079

Will Africans take COVID-19 vaccination?

The economic and humanistic impact of COVID-19 pandemic is enormous globally. No definitive treatment exists, hence accelerated development and approval of COVID-19 vaccines, offers a unique opportunity for COVID-19 prevention and control. Vaccine hesitancy may limit the success of vaccine distribution in Africa, therefore we assessed the potentials for coronavirus vaccine hesitancy and its determinants among Africans. An online crosssectional African-wide survey was administered in Arabic, English, and French languages. Questions on demographics, self-reported health status, vaccine literacy, knowledge and perception on vaccines, past experience, behavior, infection risk, willingness to receive and affordability of the SARS-COV-2 vaccine were asked. Data were subjected to descriptive and inferential statistics. A total of 5,416 individuals completed the survey. Approximately, 94% were residents of 34 African countries while the other Africans live in the Diaspora. Only 63% of all participants surveyed were willing to receive the COVID-19 vaccination as soon as possible and 79% were worried about its side effects. Thirty-nine percent expressed concerns of vaccine-associated infection. The odds of vaccine hesitancy was 0.28 (95% CI: 0.22, 0.30) among those who believed their risk of infection was very high, compared to those who believed otherwise. The odds of vaccine hesitancy was one-fifth (OR = 0.21, 95% CI: 0.16, 0.28) among those who believed their risk of falling sick was very high, compared to those who believed their risk of falling very sick was very low. The OR of vaccine hesitancy was 2.72 (95% CI: 2.24, 3.31) among those who have previously refused a vaccine for themselves or their child compared to counterparts with no self-reported history of vaccine hesitancy. Participants want the vaccines to be mandatory (40%), provided free of charge (78%) and distributed in homes and offices (44%). COVID-19 vaccine hesitancy is substantial among Africans based on perceived risk of coronavirus infection and past experiences.http://www.plosone.orgam2022Veterinary Tropical Disease

Will Africans take COVID-19 vaccination?

The economic and humanistic impact of COVID-19 pandemic is enormous globally. No definitive treatment exists, hence accelerated development and approval of COVID-19 vaccines, offers a unique opportunity for COVID-19 prevention and control. Vaccine hesitancy may limit the success of vaccine distribution in Africa, therefore we assessed the potentials for coronavirus vaccine hesitancy and its determinants among Africans. An online cross-sectional African-wide survey was administered in Arabic, English, and French languages. Questions on demographics, self-reported health status, vaccine literacy, knowledge and perception on vaccines, past experience, behavior, infection risk, willingness to receive and affordability of the SARS-COV-2 vaccine were asked. Data were subjected to descriptive and inferential statistics. A total of 5,416 individuals completed the survey. Approximately, 94% were residents of 34 African countries while the other Africans live in the Diaspora. Only 63% of all participants surveyed were willing to receive the COVID-19 vaccination as soon as possible and 79% were worried about its side effects. Thirty-nine percent expressed concerns of vaccine-associated infection. The odds of vaccine hesitancy was 0.28 (95% CI: 0.22, 0.30) among those who believed their risk of infection was very high, compared to those who believed otherwise. The odds of vaccine hesitancy was one-fifth (OR = 0.21, 95% CI: 0.16, 0.28) among those who believed their risk of falling sick was very high, compared to those who believed their risk of falling very sick was very low. The OR of vaccine hesitancy was 2.72 (95% CI: 2.24, 3.31) among those who have previously refused a vaccine for themselves or their child compared to counterparts with no self-reported history of vaccine hesitancy. Participants want the vaccines to be mandatory (40%), provided free of charge (78%) and distributed in homes and offices (44%). COVID-19 vaccine hesitancy is substantial among Africans based on perceived risk of coronavirus infection and past experiences

Will Africans take COVID-19 vaccination?

The economic and humanistic impact of COVID-19 pandemic is enormous globally. No definitive treatment exists, hence accelerated development and approval of COVID-19 vaccines, offers a unique opportunity for COVID-19 prevention and control. Vaccine hesitancy may limit the success of vaccine distribution in Africa, therefore we assessed the potentials for coronavirus vaccine hesitancy and its determinants among Africans. An online cross-sectional African-wide survey was administered in Arabic, English, and French languages. Questions on demographics, self-reported health status, vaccine literacy, knowledge and perception on vaccines, past experience, behavior, infection risk, willingness to receive and affordability of the SARS-COV-2 vaccine were asked. Data were subjected to descriptive and inferential statistics. A total of 5,416 individuals completed the survey. Approximately, 94% were residents of 34 African countries while the other Africans live in the Diaspora. Only 63% of all participants surveyed were willing to receive the COVID-19 vaccination as soon as possible and 79% were worried about its side effects. Thirty-nine percent expressed concerns of vaccine-associated infection. The odds of vaccine hesitancy was 0.28 (95% CI: 0.22, 0.30) among those who believed their risk of infection was very high, compared to those who believed otherwise. The odds of vaccine hesitancy was one-fifth (OR = 0.21, 95% CI: 0.16, 0.28) among those who believed their risk of falling sick was very high, compared to those who believed their risk of falling very sick was very low. The OR of vaccine hesitancy was 2.72 (95% CI: 2.24, 3.31) among those who have previously refused a vaccine for themselves or their child compared to counterparts with no self-reported history of vaccine hesitancy. Participants want the vaccines to be mandatory (40%), provided free of charge (78%) and distributed in homes and offices (44%). COVID-19 vaccine hesitancy is substantial among Africans based on perceived risk of coronavirus infection and past experiences.</p